Yonghe Medical Group (02279) Announces Monthly Return for February 2026
Bulletin Express
Mar 03
Yonghe Medical Group Co., Ltd. (02279) disclosed its Monthly Return for Equity Issuer for the month ended 28 February 2026. The total authorized share capital remained US$50,000, represented by 20,000,000,000 ordinary shares with a par value of US$0.0000025 per share.
The number of issued shares (excluding treasury shares) remained at 525.22 million, while treasury shares remained at 0.25 million, maintaining the total issued share count at 525.47 million. The company confirmed compliance with the applicable 25% public float requirement. No share options, warrants, convertible securities, or other arrangements to issue shares were noted during the period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.